John D Couling insider trades: Dolby Laboratories (DLB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | DLB | ↓ Sell | 7,667 | $58.78 | $451K | Direct | Oct 5, 2026 (4d) |
| Aug 3, 2026 | DLB | ↓ Sell | 7,667 | $60.00 | $460K | Direct | Aug 5, 2026 (2d) |
| Jul 1, 2026 | DLB | ↓ Sell | 7,667 | $53.20 | $408K | Direct | Jul 6, 2026 (5d) |
| Jun 1, 2026 | DLB | ↓ Sell10b5-1 | 7,666 | $55.62 | $426K | Direct | Jun 3, 2026 (2d) |
| May 5, 2026 | DLB | ↓ Sell10b5-1 | 12,354 | $57.90 | $715K | Direct | May 6, 2026 (1d) |
| Feb 2, 2026 | DLB | ↓ Sell | 6,667 | $64.89 | $433K | Direct | Feb 4, 2026 (2d) |
| Dec 11, 2025 | DLB | ↓ Sell | 7,273 | $68.75 | $500K | Direct | Dec 15, 2025 (4d) |
| Nov 20, 2025 | DLB | ↓ Sell | 6,164 | $66.12 | $408K | Direct | Nov 24, 2025 (4d) |
| May 5, 2025 | DLB | ↓ Sell | 675 | $75.04 | $51K | Direct | May 7, 2025 (2d) |
| Nov 25, 2024 | DLB | ↓ Sell | 57,000 | $80.10 | $4.6M | Direct | Nov 26, 2024 (1d) |
| Feb 9, 2024 | DLB | ↓ Sell | 83,560 | $80.32 | $6.7M | Direct | Feb 12, 2024 (3d) |
| Nov 15, 2023 | DLB | ↓ Sell | 79 | $88.58 | $7K | Direct | Nov 17, 2023 (2d) |
| May 15, 2023 | DLB | ↓ Sell | 278 | $83.87 | $23K | Direct | May 16, 2023 (1d) |
| Feb 7, 2023 | DLB | ↓ Sell | 87,003 | $84.33 | $7.3M | Direct | Feb 8, 2023 (1d) |
| Nov 21, 2022 | DLB | ↓ Sell | 40 | $69.02 | $3K | Direct | Nov 23, 2022 (2d) |
| Oct 4, 2022 | DLB | ↓ Sell | 54,300 | $66.15 | $3.6M | Direct | Oct 5, 2022 (1d) |
| May 16, 2022 | DLB | ↓ Sell | 185 | $74.63 | $14K | Direct | May 17, 2022 (1d) |
| May 12, 2022 | DLB | ↓ Sell | 1,500 | $72.87 | $109K | Direct | May 12, 2022 (0d) |
| Nov 15, 2021 | DLB | ↓ Sell | 87 | $90.23 | $8K | Direct | Nov 17, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DLB insiders
Open-market trades in the last 12 months
About John D Couling's insider trades
John D Couling is SVP, Entertainment at Dolby Laboratories (DLB). Since Nov 15, 2021, John has reported no open-market purchases and 19 sales worth $26.2M on SEC Form 4. In the last 12 months: 8 sales ($3.8M).
2 sales (4% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (13 filings), grants and awards (6 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DLB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.